MITORX THERAPEUTICS LIMITED

Active Oxford

Research and experimental development on biotechnology

9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnologyOther business support service activities n.e.c.
M

MITORX THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 2 Mar 2021 Active Oxford, United Kingdom 9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnologyOther business support service activities n.e.c.

Previous Company Names

IFFLEY BIOTECH LTD 2 Mar 2021 — 22 Jul 2021
Accounts Due 31 Dec 2026 6 months remaining
Confirmation Submitted 9 Mar 2026 Next due 15 Mar 2027 9 months remaining
Net assets £1M £73K 2024 year on year
Total assets £2M £49K 2024 year on year
Total Liabilities £217K £25K 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

9400 Garsington Road Oxford Business Park Oxford OX4 2HN United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for MITORX THERAPEUTICS LIMITED (13237941), an active life sciences and medical technology company based in Oxford, United Kingdom. Incorporated 2 Mar 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type total-exemption-full
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£1.12M

Decreased by £125.52k (-10%)

Net Assets

£1.40M

Decreased by £73.43k (-5%)

Total Liabilities

£216.69k

Increased by £24.91k (+13%)

Turnover

N/A

Employees

9

Debt Ratio

13%

Increased by 1 (+8%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (9)

Investor NameInvestor SinceParticipating Rounds
Investor 2Apr 2022Seed
Investor 5Apr 2022Seed
Investor 6Apr 2022Seed

Share Capital

Share Capital

Share allotments and capital structure

21 Allotments 7,589,420 Shares £13.08m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
18 Dec 2025431,338£819k£1.899
18 Dec 2025427,436£811k£1.899
28 Nov 2025262,527£449k£1.709
28 Nov 2025301,406£515k£1.709
28 Nov 2025262,527£449k£1.709

Officers

Officers

3 active
Status
Cowling, Didier Shaun PhilipDirectorBritish,frenchSwitzerland6112 Nov 2025Active
Matthew Loren WhitemanDirectorBritishUnited Kingdom5422 Sept 2021Active
Norman Milne LawDirectorBritishEngland632 Mar 2021Active

Shareholders

Shareholders (105)

Oshen Holdings Sa
16.6%
2,106,926
University Of Exeter
7.0%
885,700

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Jonathan David Rees

Ceased 25 Jan 2022

Ceased

Norman Milne Law

Ceased 25 Jan 2022

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
14 Apr 2026MiscellaneousReplacement filing of SH01 - 28/11/25 Statement of Capital gbp 958.122
14 Apr 2026MiscellaneousReplacement filing of SH01 - 28/11/25 Statement of Capital gbp 908.1721
19 Mar 2026OfficersAppointment of Mr Mohammad Sohail Fazeli as director on 17 Mar 2026
9 Mar 2026Confirmation StatementConfirmation statement made on 1 Mar 2026 with updates
22 Jan 2026ResolutionResolutions
14 Apr 2026 Miscellaneous

Replacement filing of SH01 - 28/11/25 Statement of Capital gbp 958.122

14 Apr 2026 Miscellaneous

Replacement filing of SH01 - 28/11/25 Statement of Capital gbp 908.1721

19 Mar 2026 Officers

Appointment of Mr Mohammad Sohail Fazeli as director on 17 Mar 2026

9 Mar 2026 Confirmation Statement

Confirmation statement made on 1 Mar 2026 with updates

22 Jan 2026 Resolution

Resolutions

Recent Activity

Latest Activity

Replacement filing of SH01 - 28/11/25 Statement of Capital gbp 958.122

1 months ago on 14 Apr 2026

Replacement filing of SH01 - 28/11/25 Statement of Capital gbp 908.1721

1 months ago on 14 Apr 2026

Appointment of Mr Mohammad Sohail Fazeli as director on 17 Mar 2026

2 months ago on 19 Mar 2026

Confirmation statement made on 1 Mar 2026 with updates

2 months ago on 9 Mar 2026

Resolutions

4 months ago on 22 Jan 2026